Maria Vrontakis

1.6k total citations
33 papers, 1.4k citations indexed

About

Maria Vrontakis is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Maria Vrontakis has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cellular and Molecular Neuroscience, 9 papers in Molecular Biology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Maria Vrontakis's work include Neuropeptides and Animal Physiology (23 papers), Hypothalamic control of reproductive hormones (7 papers) and Growth Hormone and Insulin-like Growth Factors (7 papers). Maria Vrontakis is often cited by papers focused on Neuropeptides and Animal Physiology (23 papers), Hypothalamic control of reproductive hormones (7 papers) and Growth Hormone and Insulin-like Growth Factors (7 papers). Maria Vrontakis collaborates with scholars based in Canada, Greece and United States. Maria Vrontakis's co-authors include Henry G. Friesen, Mary Lynn Duckworth, Nisha Singh, Fiona E. Parkinson, Prashen Chelikani, Ingo Schroedter, Dimitrios G. Goulis, Antonio Torsello, A. Souvatzoglou and Tooru M. Mizuno and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Maria Vrontakis

33 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Vrontakis Canada 20 754 461 319 293 280 33 1.4k
Pierre Fontanaud France 22 324 0.4× 519 1.1× 394 1.2× 112 0.4× 180 0.6× 43 1.4k
Å. Dagerlind Sweden 23 1.1k 1.5× 699 1.5× 113 0.4× 79 0.3× 155 0.6× 47 1.7k
Michio Niimi Japan 22 382 0.5× 266 0.6× 398 1.2× 132 0.5× 224 0.8× 53 1.4k
Chrystel Lafont France 20 140 0.2× 417 0.9× 360 1.1× 147 0.5× 146 0.5× 28 1.3k
Hideki Katakami Japan 28 471 0.6× 433 0.9× 945 3.0× 350 1.2× 291 1.0× 87 2.0k
Andre H. Lagrange United States 22 530 0.7× 539 1.2× 174 0.5× 343 1.2× 32 0.1× 50 1.5k
Y. Lee Japan 9 898 1.2× 431 0.9× 60 0.2× 113 0.4× 196 0.7× 9 1.1k
Krisztina Szabadfi Hungary 24 854 1.1× 669 1.5× 88 0.3× 60 0.2× 302 1.1× 43 1.3k
Tamás Atlasz Hungary 25 917 1.2× 808 1.8× 88 0.3× 52 0.2× 300 1.1× 65 1.4k
Alana Jackman United States 7 585 0.8× 457 1.0× 51 0.2× 56 0.2× 360 1.3× 9 1.5k

Countries citing papers authored by Maria Vrontakis

Since Specialization
Citations

This map shows the geographic impact of Maria Vrontakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Vrontakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Vrontakis more than expected).

Fields of papers citing papers by Maria Vrontakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Vrontakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Vrontakis. The network helps show where Maria Vrontakis may publish in the future.

Co-authorship network of co-authors of Maria Vrontakis

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Vrontakis. A scholar is included among the top collaborators of Maria Vrontakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Vrontakis. Maria Vrontakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eslava‐Schmalbach, Javier, Maria Vrontakis, Justo P. Castaño, et al.. (2016). Serum Galanin Levels in Young Healthy Lean and Obese Non-Diabetic Men during an Oral Glucose Tolerance Test. Scientific Reports. 6(1). 31661–31661. 13 indexed citations
2.
Zhang, Lin, et al.. (2016). Changes in Galanin Systems in a Rat Model of Post-Traumatic Stress Disorder (PTSD). PLoS ONE. 11(12). e0167569–e0167569. 6 indexed citations
3.
Zhang, Lixia, et al.. (2014). An elevated level of circulating galanin promotes developmental expression of myelin basic protein in the mouse brain. Neuroscience. 284. 581–589. 5 indexed citations
4.
Wang, Huiying, Lin Zhang, Sa Li, et al.. (2013). Orexins (hypocretins) contribute to fear and avoidance in rats exposed to a single episode of footshocks. Brain Structure and Function. 219(6). 2103–2118. 50 indexed citations
5.
6.
Zhang, Lin, et al.. (2012). Galanin Transgenic Mice with Elevated Circulating Galanin Levels Alleviate Demyelination in a Cuprizone-Induced MS Mouse Model. PLoS ONE. 7(3). e33901–e33901. 24 indexed citations
7.
Singh, Nisha, Maria Vrontakis, Fiona E. Parkinson, & Prashen Chelikani. (2011). Functional bitter taste receptors are expressed in brain cells. Biochemical and Biophysical Research Communications. 406(1). 146–151. 146 indexed citations
8.
Jones, Melissa K., et al.. (2009). Presence of Galanin‐Like Immunoreactivity in Mesenchymal and Neural Crest Origin Tissues During Embryonic Development in the Mouse. The Anatomical Record. 292(4). 481–487. 8 indexed citations
9.
Mizuno, Tooru M., et al.. (2009). Chronic increase of circulating galanin levels induces obesity and marked alterations in lipid metabolism similar to metabolic syndrome. International Journal of Obesity. 33(12). 1381–1389. 64 indexed citations
10.
Vrontakis, Maria, et al.. (2003). Transgenic mice over-expressing galanin exhibit pituitary adenomas and increased secretion of galanin, prolactin and growth hormone. Journal of Endocrinology. 179(2). 145–154. 30 indexed citations
11.
Vrontakis, Maria. (2002). Galanin: A Biologically Active Peptide. PubMed. 1(6). 531–541. 65 indexed citations
12.
Vrontakis, Maria, Antonio Torsello, Valeriano Leite, Jean‐Claude Vuille, & Hong Zhang. (1996). Regulation of Galanin by Dexamethasone in the Rat Anterior Pituitary and the Uterus. Neuroendocrinology. 64(1). 20–24. 8 indexed citations
14.
Chakraborty, Chandan, Maria Vrontakis, Péter Molnár, et al.. (1995). Expression of pituitary peptide 23 in the rat uterus: regulation by estradiol. Molecular and Cellular Endocrinology. 108(1-2). 149–154. 13 indexed citations
15.
Leite, Valeriano, Maria Vrontakis, Siegfried Kasper, & Henry G. Friesen. (1993). Bromocriptine Inhibits Galanin Gene Expression in the Rat Pituitary Gland. Molecular and Cellular Neuroscience. 4(5). 418–423. 1 indexed citations
16.
Vrontakis, Maria, Antonio Torsello, & Henry G. Friesen. (1991). Galanin. Journal of Endocrinological Investigation. 14(9). 785–794. 44 indexed citations
17.
Vrontakis, Maria, T Sano, Kálmán Kovács, & Henry G. Friesen. (1990). Presence of Galanin-Like Immunoreactivity in Nontumorous Corticotrophs and Corticotroph Adenomas of the Human Pituitary. The Journal of Clinical Endocrinology & Metabolism. 70(3). 747–751. 59 indexed citations
18.
Vrontakis, Maria, Toshiharu Yamamoto, Ingo Schroedter, J.I. Nagy, & Henry G. Friesen. (1989). Estrogen induction of galanin synthesis in the rat anterior pituitary gland demonstrated by in situ hybridization and immunohistochemistry. Neuroscience Letters. 100(1-3). 59–64. 82 indexed citations
19.
Gurr, James A., et al.. (1986). Hormonal Regulation of Thyrotropin Alpha and Beta Subunit mRNAs. Hormone and Metabolic Research. 18(6). 382–385. 16 indexed citations
20.
Koutras, Demetrios A., et al.. (1983). Thyroid Hormone and Immunological Studies in Endemic Goiter*. The Journal of Clinical Endocrinology & Metabolism. 57(4). 859–862. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026